[1] |
Sharshar T, Chevret S, Bourdain F, et al. Early predictors of mechanical ventilation in Guillain-Barré syndrome[J]. Crit Care Med, 2003, 31(1): 278-283.
|
[2] |
中华医学会神经病学分会神经肌肉病学组,中华医学会神经病学分会肌电图及临床神经电生理学组,中华医学会神经病学分会神经免疫学组,等.中国吉兰巴雷综合征诊治指南[J].中华神经科杂志, 2010, 43(8): 583-586.
|
[3] |
Pithadia AB, Kakadia N. Guillain-Barré syndrome(GBS)[J]. Pharmacol Rep, 2010, 62(2): 220-232.
|
[4] |
Atkinson SB, Carr RL, Maybee P, et al. The challenges of managing and treating Guillain-Barré syndrome during the acute phase[J]. Dimens Crit Care Nurs, 2006,25(6): 256-263.
|
[5] |
Ruts L, Drenthen J, Jongen JL, et al. Pain in Guillain-Barre syndrome: a long-term follow-up study[J]. Neurology, 2010, 75(16): 1439-1447.
|
[6] |
Kuwabara S. Guillain-Barré syndrome: epidemiology, pathophysiology and management[J]. Drugs, 2004, 64(6): 597-610.
|
[7] |
Souayah N, Yacoub HA, Khan HM, et al. Analysis of data from the CDC/FDA vaccine adverse event reporting system(1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA[J]. J Clin Neurosci, 2012, 19(8): 1089-1092.
|
[8] |
李静,张振国,郝玲,等.河北省甲型H1N1流感裂解疫苗大规模接种前后格林巴利综合征发病流行病学分析[J].医学动物防制, 2014, 30(12):1333-1335, 1338.
|
[9] |
Rajasekaran D, Subbaraghavalu G, Jayapandian P. Guillain-Barre syndrome due to organophosphate compound poison[J]. J Assoc Physicians India, 2009, 57: 714-715.
|
[10] |
Vatandoust S, Joshi R, Price TJ. Guillain-Barre syndrome in colorectal cancer[J]. Asia Pac J Clin Oncol, 2012, 8(2): 205-208.
|
[11] |
史晶华.变异型格林-巴利综合征误诊临床分析10例[J].中国社区医师, 2014, 30(3): 98-99.
|
[12] |
Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome[J]. Arch Neurol, 1986, 43(11): 1150-1152.
|
[13] |
Edvardsson B, Persson S. Polyneuritis cranialis presenting with anti-GQ1b IgG antibody[J]. J Neurol Sci, 2009, 281(1-2): 125-126.
|
[14] |
Saifudheen K, Jose J, Gafoor A, et al. Guillain-Barre syndrome and SIADH[J]. Neurology, 2011, 76(8): 701-704.
|
[15] |
Penney MD, Murphy D, Walters G. Resetting of osmoreceptor response as cause of hyponatraemia in acute idiopathic polyneuritis[J]. Br Med J, 1979, 2(6203): 1474-1476.
|
[16] |
张晓明,张元伟,李新立,等.格林-巴利综合征严重程度与脑脊液蛋白含量的关系[J].实用医药杂志, 2007, 24(8): 919-920.
|
[17] |
Yikilmaz A, Doganay S, Gumus H, et al. Magnetic resonance imaging of childhood Guillain-Barre syndrome[J]. Childs Nerv Syst, 2010, 26(8): 1103-1108.
|
[18] |
Ma YM, Liu TK, Wong V. Guillain-Barre syndrome in southern Chinese children: 32 year experience in Hong Kong[J]. Pediatr Int, 2010, 2(1): 13-19.
|
[19] |
Hughes RA, Raphaël JC, Swan AV, et al. Intravenous immunoglobulin for Guillain-Barré syndrome[J]. Cochrane Database Syst Rev, 2001(2): CD002063.
|
[20] |
许红玉,梅育嘉.吉兰-巴雷综合征的研究进展[J].医学综述, 2014, 20(5): 878-880.
|
[21] |
王坤亮,朱家攀.大剂量丙种球蛋白联合甲基强的松龙治疗急性格林巴利综合征36例疗效观察[J].中国伤残医学, 2014, (4): 139-139.
|
[22] |
Yuki N, Hartung HP. Guillain-Barré Syndrome[J]. N Engl J Med, 2012, 366(24): 2294-2304.
|
[23] |
Hughes RA, Swan AV, Raphaël JC, et al. Immunotherapy for Guillain-Barré syndrome: a systematic review[J]. Brain, 2007, 130(9): 2245-2257.
|
[24] |
EI Mhandi L, Calmels P, Camdessanché JP, et al. Muscle strength recovery in treated Guillain-Barré syndrome: a prospective study for the first 18 months after onset[J]. Am J Phys Med Rehabil, 2007, 86(9): 716-724.
|
[25] |
Zhang G, Lehmann HC, Bogdanova N, et al. Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy[J]. PLoS One, 2011, 6(10): e27067.
|
[26] |
Pineda AA, Minohara M, Kawamura N, et al. Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis[J]. J Neurol Sci, 2011, 306(1-2): 115-120.
|